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1422Outcomes After Complete Versus Incomplete Revascularization of Patients
With Multivessel Coronary Artery DiseaseA Meta-Analysis of 89,883 Patients Enrolled in Randomized Clinical Trials and
Observational StudiesObjectives This study sought to perform a systematic review and meta-analysis of studies comparing complete
revascularization (CR) versus incomplete revascularization (IR) in patients with multivessel coronary artery disease.Background There are conﬂicting data regarding the beneﬁts of CR in patients with multivessel coronary artery disease.Methods We identiﬁed observational studies and subgroup analysis of randomized clinical trials (RCT) published in PubMed
from 1970 through September 2012 using the following keywords: “percutaneous coronary intervention” (PCI);
“coronary artery bypass graft” (CABG); “complete revascularization”; and “incomplete revascularization.” Main
outcome measures were total mortality, myocardial infarction, and repeat revascularization procedures.Results We identiﬁed 35 studies including 89,883 patients, of whom 45,417 (50.5%) received CR and 44,466 (49.5%)
received IR. IR was more common after PCI than after CABG (56% vs. 25%; p < 0.001). Relative to IR, CR was
associated with lower long-term mortality (risk ratio [RR]: 0.71, 95% conﬁdence interval [CI]: 0.65 to 0.77;
p< 0.001), myocardial infarction (RR: 0.78, 95% CI: 0.68 to 0.90; p¼ 0.001), and repeat coronary revascularization
(RR: 0.74, 95% CI: 0.65 to 0.83; p < 0.001). The mortality beneﬁt associated with CR was consistent across studies
irrespective of revascularization modality (CABG: RR: 0.70, 95% CI: 0.61 to 0.80; p < 0.001; and PCI: RR: 0.72, 95%
CI: 0.64 to 0.81; p < 0.001) and deﬁnition of CR (anatomic deﬁnition: RR: 0.73, 95% CI: 0.67 to 0.79; p < 0.001;
and nonanatomic deﬁnition: RR: 0.57, 95% CI: 0.36 to 0.89; p ¼ 0.014).Conclusions CR is achieved more commonly with CABG than with PCI. Among patients with multivessel coronary artery disease,
CR may be the optimal revascularization strategy. (J Am Coll Cardiol 2013;62:1421–31) ª 2013 by the American
College of Cardiology FoundationOver 1,000,000 coronary revascularization procedures are
performed every year in the United States for the treatment
of coronary artery disease (CAD) (1). Coronary revascular-
ization improves symptoms and, in select groups, reduces
myocardial infarction and long-term mortality (2–5).
See page 1432
Achieving complete revascularization (CR) has long been
a goal of coronary artery bypass graft (CABG) surgery (6,7).
A seminal observation from the CASS (Coronary Artery
Surgery Study) registry showed that patients with multi-
vessel CAD and severe angina that received 3 or more grafts
had better survival relative to patients who received 1 or 2
grafts (8). By extension, the concept of CR has also been
advocated in percutaneous coronary intervention (PCI)
(9,10). Despite this long-held belief, observational studies
have yielded conﬂicting results (10–12) and no large
multicenter randomized clinical trial (RCT) has ever tested
whether CR is superior to incomplete revascularization (IR).
CR is infrequent in clinical practice (10,13), and guidelines
do not formally address the issue of CR in detail (14,15).
Thus, the purpose of the present investigation was to
perform a systematic review and meta-analysis of RCTs and
observational studies to determine if CR is associated with
improved clinical outcomes compared with outcomes of IR.Methods
We identiﬁed observational studies and RCTs published in
PubMed from 1970 through September 2012 using the
following keywords: “percutaneous coronary intervention”;
“coronary artery bypass graft”; “complete revascularization”;
and “incomplete revascularization.” We limited our search
criteria to include studies published in the English language
and those involving humans. We identiﬁed additional stu-
dies by searching Clinicaltrials.gov and by hand-searching
references cited in relevant publications. This methodolog-
ical approach has been previously validated (16). “RCT,” as
used throughout this paper, refers to the design of the
study from which the data was obtained. It does not imply
that the randomization variable was completeness of
revascularization.
Data sources and study search strategy. We included
observational studies and RCTs that: 1) enrolled patients
with multivessel CAD referred for coronary revasculariza-
tion with CABG or PCI; 2) compared the outcomes of CR
versus IR using any of the deﬁnitions listed in Online
Table 1 (14); and 3) reported long-term mortality rates.
We excluded: 1) studies assessing the role of PCI on
the nonculprit vessel for the treatment of ST-segment
elevation myocardial infarction; 2) studies comparing
outcomes of PCI for chronic total occlusion (CTO)
(success vs. failure) unless the degree of completeness of
revascularization was also reported; 3) studies that
Abbreviations
and Acronyms
CABG = coronary artery
bypass graft
CAD = coronary artery
disease
CI = conﬁdence interval
CR = complete
revascularization
CTO = chronic total
occlusion
FFR = fractional-ﬂow reserve
IR = incomplete
revascularization
MI = myocardial infarction
OR = odds ratio
PCI = percutaneous coronary
intervention
RCT = randomized clinical
trial
RR = risk ratio
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1423focused on patients with redo-CABG; and 4) single-
center studies with small sample size (100 patients in
each treatment arm).
Study selection. Our initial search yielded 6,668 citations
(Fig. 1). Of these, 6,134 (92%) were excluded by title search
because of irrelevant content, animal subjects, or publication
in a language other than English. The abstracts of the
remaining 534 studies were reviewed. Of these, 109 abstracts
were deemed eligible for full-text manuscript review, and
425 (79.5%) were excluded for various reasons (Fig. 1). Of
the 109 full-text manuscripts reviewed for eligibility, 24 met
the inclusion criteria. An additional 11 manuscripts were
identiﬁed through hand-searching leading to a total of 35
studies included in this meta-analysis.
Data extraction. Data were abstracted by 2 reviewers (S.G.
and Y.S.) using standardized data extraction forms. Discrep-
ancies were resolved by consensus. Abstracted information
included study design, time frame, key patient and proce-
dural characteristics, and relevant outcomes. For RCTs that
reported outcomes forCABGandPCI separately, wemade 2
entries, 1 for each revascularization modality. When out-
comes were not reported separately, we included the study in
the main analysis but not in the subgroup analysis of revas-
cularization modalities.
Outcomes. The primary outcome for this systematic review
was all-cause mortality. Secondary outcomes were myocardial
infarction (MI) and repeat revascularization.
Methodological quality. Study selection, data collection,
analysis, and reporting of the results were performed using the
recommendations of the MOOSE (Meta-analysis Of
Observational Studies in Epidemiology) Group (17).
Heterogeneity across trials was assessed using the Cochrane
Q-statistic (p < 0.1 was considered signiﬁcant) and
I2-statistic (18). I2 describes the percentage of total variation
across studies that is due to heterogeneity rather than chance
(18). A value of 0% indicates no heterogeneity, and larger
values indicate increased heterogeneity. Publication bias was
visually estimated by assessing funnel plots.
We calculated weighted risk ratios (RR) and 95% conﬁ-
dence intervals (CIs) for categorical variables. Each RR was
calculated according to the DerSimonian-Laird random
effects model. Automatic “zero cell” correction was used for
studies with no events for a particular outcome. All analyses
were performed using STATA software (version 10.1, Sta-
taCorp, College Station, Texas).
Results
Study and patient characteristics. The characteristics of
the 35 studies that met eligibility criteria are displayed in
Table 1 and Online Appendix 1. A full listing of all 35
papers is provided in Online Appendix 2. Of these, 28 were
observational studies, 5 were subgroup analysis of RCTs, 1
was a subgroup analysis of a non-RCT, and 1 was a single-
center RCT comparing CR versus IR. Four of the 35 studies
reported outcomes for PCI and CABG separately, resultingin 39 entries (Table 1). Of the 39
study entries, 34 (87%) used an
anatomic deﬁnition of CR, 2
(5%) a functional deﬁnition, 2
(5%) a numerical deﬁnition, and
1 (2.5%) multiple deﬁnitions of
CR. The funnel plots were not
suggestive of a publication bias
(Online Figs. 1 to 3). Online
Appendix 3 contains the deﬁni-
tion of MI used in each study.
The present analysis includes
89,883 patients, of which 45,417
(50.5%) received CR and 44,466
(49.5%) received IR. The revas-
cularization modality was CABG
for 25,938 patients (29%) and
PCI for the remaining 63,945
patients (71%).
Mean age of the study partic-
ipants was 63  7 years, 74%
were male, 25% had diabetes
mellitus, and 43% had a previous MI. The mean follow-up
time was 4.6  4 years.
Mortality. Of the 89,883 patients included in this meta-
analysis, 12,259 (13%) died during follow-up. CR was
associated with reduced long-term mortality relative to IR
(RR: 0.71; 95% CI: 0.65 to 0.77; p < 0.001, I2 ¼ 71%)
(Fig. 2, Online Table 2). The mortality beneﬁt was observed
in patients treated with CABG and PCI (CABG: RR: 0.70,
95% CI: 0.61 to 0.80; p < 0.001; I2 ¼ 80%; and PCI: RR:
0.72, 95% CI: 0.64 to 0.81; p < 0.001; I2 ¼ 62%) (Figs. 3
and 4). Likewise, the mortality beneﬁt associated with CR
was seen in RCTs (RR: 0.76, 95% CI: 0.62 to 0.92;
p ¼ 0.006; I2 ¼ 0%) and observational studies (RR: 0.70,
95% CI: 0.64 to 0.77; p< 0.001, I2¼ 78%) and did not vary
substantially with the deﬁnition of CR (anatomic RR: 0.73,
95% CI: 0.67 to 0.79; p < 0.001; I2 ¼ 65%; and nonana-
tomic RR: 0.54; 95% CI: 0.36 to 0.89; p ¼ 0.01; I2 ¼ 88%).
Myocardial infarction. Eighteen of 35 studies reported
1,509 MI during follow-up. Compared with IR, CR was
associated with lower risk of MI (RR: 0.78, 95% CI: 0.68 to
0.90; p ¼ 0.001; I2 ¼ 19%). A reduction in MI was observed
among PCI-treated patients (PCI: RR: 0.80, 95% CI: 0.71
to 0.91; p ¼ 0.001; I2 ¼ 0%) but not among CABG-treated
patients (CABG: RR: 0.69, 95% CI: 0.44 to 1.10; p ¼ 0.12;
I2 ¼ 62%). The lower risk of MI was seen in RCTs (RR:
0.72, 95% CI: 0.61 to 0.86; p < 0.001; I2 ¼ 0%), obser-
vational studies (RR: 0.78, 95% CI: 0.61 to 1.00; p ¼ 0.05;
I2 ¼ 44%), and studies that used an anatomic deﬁnition of
CR (RR: 0.72, 95% CI: 0.63 to 0.83; p < 0.001; I2 ¼ 0.3%).
Only 1 study reported MI rates using a nonanatomic deﬁ-
nition of CR (RR: 0.99, 95% CI: 0.74 to 1.25; p ¼ 0.79).
Repeat coronary revascularization. Twenty of 35 studies
reported 5,756 repeat revascularization procedures during
follow-up. Compared with IR, CR was associated with lower
Manuscripts included 
through database 
searching
(n=24)
Records identified 
through  database 
searching
(n=6668)
Non-Human and/or
non-English (n=903)
Abstracts after non-
human and non-
English studies 
excluded
(n=5765)
Potential relevant 
abstracts reviewed
(n=534)
Abstracts excluded (n=425) (79.5%) 
[69 Studies have >1 reason for exclusion}
STEMI: n=25
Study design: n=52 (i.e. case reports, letters to 
the editor, review articles)
CTO: n=16
Outcomes of interest not reported: n=31
Absence IR vs. CR comparison: n=369
Studies excluded by non-relevant title
n=5231 ( 90.7%)
Full text articles 
assessed for eligibility 
(n=109)
Studies included
in meta-analysis
(n=35)
Full text articles excluded (n=85)
Absence IR vs. CR comparison: n=37 
Event rates not reported: n=19 
STEMI or Shock population: n=4 
Small sample size: n=11 
CTO: n=1 
Only post-procedural outcomes: n=1 
Reoperation: n=3 
Event rates reported for CR only: n=1 
Hybrid Procedures: n=1 
Duplicate dataset: n=4 
Multivessel PCI without mention of CR: n=1
CR not defined: n=1 
Not a multivessel disease cohort: n=1
Records identified 
through hand searching
(n=11)
Figure 1 Flow Diagram of the Literature Search and Study Selection
A total of 6,668 citations were identiﬁed through database searching and 109 full text manuscripts were reviewed for eligibility, of which 24 met the inclusion criteria. Eleven
manuscripts were identiﬁed through hand searching, leading to a total of 35 studies included in this meta-analysis. CR ¼ complete revascularization; CTO ¼ chronic total
occlusions; IR ¼ incomplete revascularization; PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevation myocardial infarction.
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1424risk of repeat revascularization procedures (RR: 0.74, 95%
CI: 0.65 to 0.83; p < 0.001; I2 ¼ 65%). CR was associated
with fewer repeat revascularization procedures among PCI-
treated patients (RR: 0.72, 95% CI: 0.63 to 0.81; p < 0.001;
I2¼ 70%) but not among CABG-treated patients (RR: 0.92,
95% CI: 0.67 to 1.28; p ¼ 0.64; I2 ¼ 22%). The beneﬁt of
CR in reducing repeat revascularization procedures was seen
inRCTs (RR: 0.67, 95%CI: 0.60 to 0.75; p< 0.001; I2¼ 0%)
and observational studies (RR: 0.79, 95% CI: 0.66 to 0.95;
p ¼ 0.01; I2 ¼ 76%). CR was associated with a reduced needfor repeat coronary revascularization in studies that used an
anatomic deﬁnition of CR (RR: 0.74, 95% CI: 0.66 to 0.83;
p < 0.001; I2 ¼ 54%). Only 1 study reported repeat revas-
cularization rates using a nonanatomic deﬁnition of CR
(RR: 0.55, 95% CI: 0.44 to 0.67; p < 0.001).
Discussion
The results of this systematic review and meta-analysis of CR
versus IR in patients with multivessel CAD show that CR is
JACC Vol. 62, No. 16, 2013 Garcia et al.
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1425more often achieved with CABG than with PCI and
is associated with a 30% reduction in long-term mortality,
a 22% reduction inMI, and a 26% reduction in repeat coronary
revascularization procedures. The lower mortality associated
with CR was seen in both PCI- and CABG-treated patients
andwas independent of the study design and deﬁnition of CR.
The association between CR and lower risk for subse-
quent cardiovascular events may be causal. CR may improve
clinical outcomes by reducing or eliminating myocardial
ischemia, which has been linked to worse prognosis, espe-
cially when large (19). CR may improve exercise capacity,
reduce the risk of arrhythmic events, and improve tolerance
to future acute coronary ischemic events (20). Alternatively,
IR may be a surrogate marker for higher baseline ischemic
burden and more advanced CAD that is less amenable to
revascularization by either PCI or CABG.
The ﬁndings of this study have several practical implica-
tions for cardiologists and surgeons alike. First, given the
strong clinical beneﬁt in patients with multivessel disease,
CR may be the optimal revascularization strategy. The
likelihood of achieving CR with either revascularization
modality, ideally estimated by a heart team approach, should
inﬂuence the decision to proceed with CABG or PCI. With
this approach in the SYNTAX (Synergy Between PCI With
Taxus and Cardiac Surgery) trial (21), the rates of IR were
43.3% for PCI and 36.8% for CABG, which compares
favorably with historical cohorts (13), while still highlighting
the procedural complexity of achieving CR. The most
common reasons for not achieving CR with PCI in
SYNTAX were the presence of CTO (odds ratio [OR]: 2.46,
95%CI: 1.81 to 3.39; p< 0.01), bifurcation disease (OR: 1.44,
95% CI: 1.09 to 1.89; p ¼ 0.01), and diffuse disease or small
vessels (<2 mm) (OR: 1.53, 95%CI: 1.12 to 2.10, p< 0.008)
(22). Overall, the SYNTAX score, a surrogate marker for
disease complexity, was higher in IR than in CR patients (31.4
 11 vs. 26.2  10; p < 0.01) (22). Many of the barriers
for achieving CR with PCI are no longer insurmountable
(23). For example, CTO-PCI has evolved dramatically over
the last decade with experienced operators reporting recan-
alization rates of 80% to 90% with advanced CTO tech-
niques such as dual injections, antegrade dissection re-entry,
and retrograde wiring (24–26). The most common reasons
for not achieving CR with CABG were unstable angina
presentation (OR: 1.37, 95% CI: 1.01 to 1.85; p ¼ 0.04),
diffuse disease or small vessels (OR: 2.10, 95% CI: 1.51
to 2.93; p < 0.001), and number of lesions (OR: 1.71, 95%
CI: 1.55 to 1.90; p< 0.001) (20). Some of those barriers may
be hard to overcome; bypassing small vessels is associated
with higher rates of saphenous vein graft failure, and some
patients may not have enough saphenous vein conduits to
allow revascularization of all potential coronary targets. Based
on data from the BARI (Bypass Angioplasty Revasculariza-
tion Investigation) trial and others (27) showing no survival
disadvantage when non–left anterior descending artery terri-
tories were left ungrafted, many surgeons have advocated the
concept of incomplete “reasonable” revascularization mainlyas an attempt to limit aortic cross-clamp time (28–31). Our
study cannot address this issue, yet it would suggest that
leaving potentially viable and graftable target coronary arteries
unrevascularized is not prudent.
Second, the mortality beneﬁt seen in this meta-analysis
with CR was of about the same magnitude (w30%) in
patients receiving CABG or PCI, which suggests that the
revascularization modality may not be as important as the
objective of achieving CR is. For example, in the SYNTAX
trial for patients in the lowest tercile of the SYNTAX score
(22), IR rates between PCI and CABG were not dissimilar
(31% vs. 27%) and no statistical difference in major adverse
cardiac or cerebrovascular events was seen between PCI
(13.6%) and CABG (14.7%) at 1-year (p ¼ 0. 71) (21). In
contrast, for patients in the highest tertile of the SYNTAX
score (33) as the rates of incomplete revascularization
increased disproportionately for PCI patients (57%) so did
major adverse cardiac or cerebrovascular events rates, which
were 23.4% for PCI and 10.9% for CABG (p < 0.001) at
1 year and 34% and 19% at 3 years (p < 0.001), respectively
(30). Our study extends this observation by demonstrating
that CR may provide similar relative reduction in the risk of
major adverse cardiovascular events in patients treated with
either PCI or CABG.
Third, although the majority of studies (87%) included in
this meta-analysis used an anatomic deﬁnition of CR, the
results did not change signiﬁcantly for the hard endpoint of
long-term mortality when a nonanatomic deﬁnition of CR
was used. For the outcomes of MI and repeat revasculari-
zation, only 1 study reported event rates using a nonana-
tomic deﬁnition.
The current data lacks a standardized, universal deﬁnition
of what constitutes an IR procedure (14,29). Gössl et al. (31)
recently proposed a universal deﬁnition of IR using coronary
angiography and fractional-ﬂow reserve (FFR) data. The
proposed deﬁnition of incomplete anatomic and functional
revascularization is based on the inability to treat: 1) all
coronary segments that have a 50% to 70% diameter
stenosis and an FFR 0.80; or 2) >70% stenosis without
FFR that supply a signiﬁcant degree of viable myocardium.
Based on the previous work by Piljs et al. (32) regarding the
excellent long-term outcomes of patients with intermediate
stenosis and insigniﬁcant FFR and the observation that
FFR-guided PCI in patients with multivessel CAD is
superior to angiography-guided PCI (33), a deﬁnition of IR
that includes anatomy and physiology seems intuitive,
although it requires prospective validation.
Finally, the ﬁnding that in patients treated with CABG
CR was not associated with a reduction in MI or repeat
revascularization procedures may be due to the small number
of studies that reported those outcomes. Alternatively, the
degree of completeness of revascularization may not be as
important in reducing MI or repeat procedures in CABG as
long as the 3 major epicardial vessels are grafted (27).
Study limitations. First, observational studies and post
hoc analysis of randomized clinical trials were included in
Table 1 Summary of Key Demographic Characteristics of Observational Studies and Randomized Clinical Trials Included in the Meta-Analysis
Study Name/First Author
Revascularization
Modality Study Period Study Design
Deﬁnition of
CR Used
Follow-Up,
yrs
ACS,
%*
Prevalence
of IR, %
Male Sex,
%
Mean Age,
yrs
Previous MI,
%
Diabetes,
%
ARTS I CABG/van der Brand CABG 1997–1998 Post-hoc analysis of RCT
CABG vs. PCI
Anatomic 1 36–39 16 69 61 36–43 15–23
ARTS I PCI/van der Brand PCI 1997–1999 Post-hoc analysis of RCT
CABG vs. PCI
Anatomic 1 36–40 30 79 61–62 43–44 17–19
ARTS II PCI/Sarno PCI 2003–2004 Post-hoc analysis of
non-RCT
Anatomic 5 41–49 39 77 62–63 32–36 25–26
Asian Medical Center/Kim
CABG cohort
CABG 2003–2005 Observational cohort
study CABG vs. PCI
Anatomic 5 61 33 72 61–62 22–27 38–44
Asian Medial Center/Kim
PCI cohort (1)
PCI 2003–2005 Observational cohort
study CABG vs. PCI
Anatomic 5 42 59 71 60–62 10 30–32
SYNTAX CABG/Head CABG 2005–2007 Post-hoc analysis of RCT
CABG vs. PCI
Anatomic 3 26–32 37 79 64–65 31–37 22–25
SYNTAX PCI/Head PCI 2005–2007 Post-hoc analysis of RCT
CABG vs. PCI
Anatomic 3 27–30 43 79 65 32 22–30
MASS II CABG/D’Oliveira Vieira CABG 1995–2001 Post-hoc analysis of RCT
CABG vs. PCI
Anatomic 10 0 36 72 62 55 41
MASS II PCI/D’Oliveira Vieira PCI 1995–2001 Post-hoc analysis of RCT
CABG vs. PCI
Anatomic 10 0 64 67 59 57 34
Emory/Jones CABG 1978–1981 Observational cohort
CABG study
Anatomic 5 63 27 84 54 55 NR
Cleveland/Scott CABG 1971–1997 Observational cohort
CABG study
Anatomic 20 NR 38 81 54 41 8
BARI/Van der Salm CABG 1988–1991 Post-hoc analysis of RCT
CABG vs. PCI and
observational cohort
CABG study
Multiple
deﬁnitions
7 65 17 74 62 53 19
Cedars Sinai/Kleisli CABG 1998–2000 Observational cohort
CABG study
Functional 5 NR 9 63 71 18–33 31–45
Leipzig/Rastan CABG 2000–2007 Observational cohort
CABG study
Anatomic 5 NR 10 77 67 47 31–38
Wash U/Kozower (2) CABG 1986–2003 Observational cohort
CABG study
Anatomic 8 30–34 20 52 83 NR 27–36
Bristol Heart Institute/Caputo (3) CABG 1996–2002 Observational cohort
CABG study
Numerical 2 NR 16 75 NR NR 18–20
University of Heidelberg/
Osswald (2)
CABG 1988–1999 Observational cohort
CABG study
Anatomic 0.5 NR 16 65 77 NR NR
Quebec Heart and Lung
University Institute/
Mohammadi (2)
CABG 1992–2008 Observational cohort
CABG study
Anatomic 8 33–40 18 59 82 57–70 20–27
BARI trial and registry/Kip (4) PCI 1988–1991 Post-hoc analysis of RCT
CABG vs. PCI plus
registry
Anatomic 5 NR 41 NR 61 50–56 15–20
BARI/Bourassa PCI 1988–1991 Post-hoc analysis of RCT
CABG vs. PCI
Anatomic 5 63 36 77 62 51–59 17–23
Continued on the next page
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Table 1 Continued
Study Name/First Author
Revascularization
Modality Study Period Study Design
Deﬁnition of
CR Used
Follow-Up,
yrs
ACS,
%*
Prevalence
of IR, %
Male Sex,
%
Mean Age,
yrs
Previous MI,
%
Diabetes,
%
Erasmus University/
Ijsselmuiden
PCI 1995–1998 Single-center RCT Anatomic 5 37 50 (randomized) 74 62 42 14
New York State registry/
Hannan (5)
PCI 1997–2000 Observational cohort PCI
study
Anatomic 3 NR 69 69 NR 32 71y
New York State registry/
Hannan (5)
PCI 2003–2004 Observational cohort PCI
study
Anatomic 1.5 37 69 67 NR 30–38 28–34
Careggi Hospital/Valenti (6) PCI 2003–2006 Observational cohort PCI
study
Anatomic 2 32–39 38 83 67–69 45–54 21–24
ACUITY/Genereux (7) PCI 2003–2005 Observational cohort PCI
study
Score-based 1 100 60 68 59–63 25–34 25–34
ACUITY/Rosner (8) PCI 2003–2005 Observational cohort PCI
study
Anatomic 1 100 37 69 59–61 28–31 28–31
Nikolsky (9) PCI 1992–1999 Observational cohort PCI
study
Anatomic 3 22 73 73 61 27–37 100
University of Catania/
Tamburino
PCI 2002–2005 Observational cohort PCI
study
Anatomic 3 45–55 58 79 61–63 23–33 32–35
Legnano Italy/Mariani PCI 1997–1998 Observational cohort PCI
study
Anatomic 1 100 76 83 63 41 17
NHLBI dynamic registry/
Srinivas (10)
PCI 1997–2004 Observational cohort PCI
study
Anatomic 1 34–39 78 67 61–63 20–30 29–32
Basel University Hospital/
Kloeter
PCI 1993–1997 Observational cohort PCI
study
Anatomic 2.5 NR 40 82 59 60 15
CABRI/Breeman (11) PCI 1990–1994 Post-hoc analysis of RCT Anatomic 1 25 72 81 61 40–53 9–17
Emory/Jones CABG 1978–1981 Observational cohort CABG
study
Anatomic 11 52–56 28 84 57 55–63 NR
New York State registry/Wu (12) PCI 1999–2000 Observational cohort PCI
study
Anatomic 8 NR 70 69 NR 55 27
Henan Province/Yang PCI 2003–2006 Observational cohort PCI
study
Anatomic 1.5 92 78 78 61 35 19
Duke/McNeer CABG 1969–1973 Observational cohort CABG
study
Numeric 2 NR 52 NR NR 43–58 9
Warsaw Institute of
Cardiology/Norwa-Otto
PCI 1988–1997 Observational cohort PCI
study
Functional 11 30–36 69 82 52 58–65 7
University of Toronto/Appleby PCI 2000–2007 Observational cohort PCI
study
Anatomic 3.7 53 65 72 63 32 27
Saint Louis University/Tyras CABG 1970–1977 Observational cohort CABG
study
Anatomic 4 10 29 85 52 48 16
Saint Louis University/
Deligonul
PCI 1983–1986 Observational PCI cohort
study
Anatomic 2 49 31 76 NR 45 NR
Please see Online Appendix 1 for the notes on this table.
ACS ¼ acute coronary syndrome; ACUITY ¼ Acute Catheterization and Urgent Intervention Triage Strategy; ARTS ¼ Arterial Revascularization Therapies Study; BARI ¼ Bypass Angioplasty Revascularization Investigation; CABG ¼ coronary artery bypass graft; CABRI ¼ Coronary
Angioplasty versus Bypass Revascularization Investigation; MASS II ¼ Second Medicine, Angioplasty or Surgery Study; MI ¼ myocardial infarction; NHLBI ¼ National Heart, Lung, and Blood Institute; NR ¼ not reported; PCI ¼ percutaneous coronary intervention; RCT ¼
randomized clinical trial; SYNTAX ¼ Synergy Between PCI with Taxus and Cardiac Surgery.
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Figure 2 Pooled Analysis With RR and 95% CI for the Occurrence of Total Mortality
Boxes are the relative risk estimates from each study; the horizontal bars are 95% conﬁdence intervals (CI). The size of the box is proportional to the weight of the study in the
pooled analysis. ACUITY ¼ Acute Catheterization and Urgent Intervention Triage Strategy; ARTS ¼ Arterial Revascularization Therapies Study; BARI ¼ Bypass Angioplasty
Revascularization Investigation; CABG ¼ coronary artery bypass graft; CABRI ¼ Coronary Angioplasty Versus Bypass Revascularization Investigation; NHLBI ¼ National Heart,
Lung, and Blood Institute; RR ¼ risk ratio(s); SYNTAX ¼ Synergy Between PCI With Taxus and Cardiac Surgery; other abbreviations as in Figure 1.
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1428this meta-analysis. Many of these studies had different
entry criteria, study populations, and follow-up time. This
is a source of increased heterogeneity that may limit the
generalizability of our conclusions to the broader multi-
vessel CAD population (18). However, the beneﬁcial
effects of CR in terms of reducing mortality, MI, and
repeat revascularization procedures persisted when the
analysis was restricted to RCTs with similar entry criteria
and low heterogeneity (I2 < 25%). Second, it is plausible
that IR could be a surrogate marker for residual CAD or
other important comorbidities that, though not amenable
to revascularization, would place patients at risk of adverse
clinical events (CTO, small vessel disease, etc). It should be
emphasized that only 1 RCT included in this meta-analysis
randomized patients to IR versus CR. The remainder are
direct comparisons of CABG versus PCI in which the
decision to perform IR or CR was not randomized and,
therefore, was subject to potential bias. Only an RCT
directly comparing CR versus IR can answer this question.
The ﬁnding that CR was superior to IR even in RCTs that
required equivalent complete anatomic revascularizationprior to patient enrollment suggests that selection bias alone
is unlikely to explain our ﬁndings. Third, caution is advised
when extrapolating our ﬁndings to patients with multivessel
CAD undergoing primary PCI for ST-segment elevation
myocardial infarction as these patients were not included in
our study. Fourth, the extent of IR could not be quantiﬁed.
It is possible that IR of a small myocardial territory would
carry less risk than IR of a large or multiple myocardial
segments would. Fifth, for PCI-treated patients, the
outcome of repeat coronary revascularization should be
interpreted with caution, as it is likely that in some of the
studies included in this meta-analysis staged PCI were
counted as a repeat revascularization procedure. Therefore,
repeat coronary revascularization may simply represent part
of an initial procedural strategy rather than inadequate
response to medical therapy or restenosis. Finally, the role of
contemporary medical therapy in patients with residual
CAD, although not the focus of our study, should not be
underestimated (34). Optimization and standardization of
medical therapies based on residual CAD burden has the
potential to improve clinical outcomes.
Figure 3 Pooled Analysis in CABG Studies
Pooled analysis with RR and 95% CI for the occurrence of total mortality in CABG studies.Boxes are the relative risk estimates from each study; the horizontal bars are 95% CI. The
size of the box is proportional to the weight of the study in the pooled analysis. MASS¼ Second Medicine, Angioplasty, or Surgery Study; other abbreviations as in Figures 1 and 2.
Figure 4 Pooled Analysis in PCI Studies
Pooled analysis with RR and 95% CI for the occurrence of total mortality in PCI studies. Boxes are the relative risk estimates from each study; the horizontal bars are 95% CI.
The size of the box is proportional to the weight of the study in the pooled analysis. Abbreviations as in Figures 1 and 2.
JACC Vol. 62, No. 16, 2013 Garcia et al.
October 15, 2013:1421–31 Completeness of Revascularization and Outcomes
1429
Garcia et al. JACC Vol. 62, No. 16, 2013
Completeness of Revascularization and Outcomes October 15, 2013:1421–31
1430Conclusions
In this ﬁrst systematic review and meta-analysis of CR
versus IR in patients with multivessel CAD undergoing
revascularization with CABG or PCI, CR was associated
with lower morbidity and mortality. Hence, the likelihood of
achieving CR with either revascularization modality should
inform the decision to proceed with CABG or PCI.
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